Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INEOX study of oxidative stress with basal insulin analogues in adults with type 1 diabetes
2016-002915-17Phase 4Active
- Sponsor
- Fundación IMABIS
- Start
- Aug 2016
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of insulin degludec, insulin glargine, insulin detemir, insulin glulisine, insulin lispro and 1 more in diabetes mellitus type 1 (T1D) (3 arms), sponsored by Fundación IMABIS. Started Aug 2016; status: active.
02
Drugs
insulin degludecinsulin glargineinsulin detemirinsulin glulisineinsulin lispro
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2016-002915-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002915-17.